After an emergency 50 BPS rate cut, and U.S. 10-year money hovering on both sides of 1% for the first time since forever, gold is taking on a whole new luster.
Today was a day that daytraders have been looking forward to for some time; the day that shroom stocks finally gripped the road and took off. Mind Medicine (MMED.E) ripped 90% to $0.77 on the back of 15m shares traded, reminding anyone who'd listen that ex-Canopy CEO Bruce Linton and pretend billionaire Kevin O'Leary were on board. Champignon Brands (SHRM.C) zoomed 40% to $0.33 on a lot smaller market awareness spend byt a handy ticker, Roadman Investments (LITT.V) was up 30% to $0.065 being sucked along in the other two companies' wake, and Revive Therapeutics (RVV.C) was up 81% to $0.10 on ripples caused by the rest.
Equinix (EQIX.Q) to deploy bare metal technology in their multi-cloud platform, and wtf it all means
Equinix (EQIX.Q), a company that specializes in data centers, has announced today the acquisition of bare metal automation platform, Packet.
Investors have legitimate reason to want four more years of Trump. Ignoring the recent coronavirus-catalysed carnage, the markets have performed well during the Trump presidency.
Puration (PURA.Q) verified their intention to acquire Kali Extracts (KALY.OTC) subsidiary, Kaly CBD Confection Operations earlier this week. KALY is concentrating on its cannabis extracts biopharmaceutical business. Their research thus far has been on the treatment of various respiratory conditions, with specific attention being paid to the COVID19 coronavirus.